Table 6 Distribution of PIMs
From: Polypharmacy in the oldest old (≥80 years of age) patients in China: a cross-sectional study
PIM | Drug | n | % |
|---|---|---|---|
Central nervous system drugs: estazolam, alprazolam | 10 | 14.3 | |
Drugs that should be avoided by elderly people | Gastrointestinal drugs: metoclopramide | 6 | 8.6 |
Anticholinergic drugs: diphenhydramine, chlorpheniramine | 3 | 4.3 | |
Spironolactone > 25 mg/d | 5 | 7.1 | |
Digoxin > 0.125 mg/d | 4 | 5.7 | |
Amiodarone, propafenone | 3 | 4.3 | |
Short-acting nifedipine | 7 | 10.0 | |
Prazosin, terazosin | 4 | 5.7 | |
Ibuprofen, indomethacin | 5 | 7.1 | |
Liquid paraffin | 5 | 7.1 | |
Elderly-specific disease state-related PIMs | Aspirin for heart failure | 3 | 4.3 |
Benzodiazepines for dementia and cognitive impairment | 2 | 2.9 | |
Metoclopramide for Parkinson’s disease | 3 | 4.3 | |
Theophylline for insomnia | 2 | 2.9 | |
Drugs that should be used with caution by elderly people | Aspirin for primary prevention of cardiovascular events | 8 | 11.4 |